Clinical Trial Update: GEMOX: Oxaliplatin in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating GEMOX (gemcitabine plus oxaliplatin) for pancreatic cancer. The study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Pancreatic Neoplasms | Phase 2 | Status: COMPLETED